Sphera’s Hershkovitz Discusses Novartis, Glaxo Deal (Audio)

Ori Hershkovitz, managing partner at Sphera Funds Management Ltd., discusses a swap of cancer and vaccine drugs between Novartis AG (NOVN) and GlaxoSmithKline Plc. (GSK) Hershkovitz talks with Bloomberg’s Pimm Fox and Carol Massar on Bloomberg Radio’s "Taking Stock" on April 22nd. Shannon Pettypiece, Bloomberg News health reporter, also participated in the discussion.

Running time 08:52

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.